NGS Super
VC Fund
Melbourne, Australia
NGS Super is a VC fund in Melbourne focused on Software and Aerospace. NGS Super provides SuperFund for those in non-government education and community organizations.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries NGS Super invests in
Stages NGS Super invests in
Countries NGS Super invests in
Round sizes
Round size
- Series A
- $13M–$235M
- Series B
- $20M–$29M
- Series C
- $46M–$70M
Investment Focus
Industry
- Software 2 (11%)
- Aerospace 2 (11%)
- Biotechnology 2 (11%)
- Food Processing 2 (11%)
- Food and Beverage 2 (11%)
Stage
- Series A 4 (22%)
- Series C 3 (17%)
- Series B 2 (11%)
- Series E 2 (11%)
- Series F 2 (11%)
Country
- Australia 8 (44%)
- China 2 (11%)
- United States 2 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Emesent
|
Emesent is a venture-backed technology company that automates the collection and analysis of critical data in challenging underground environments. Our flagship product is the award-winning Hovermap; a LiDAR-mapping and autonomy payload for industrial drones. Hovermap allows drones to fly and map in GPS-denied environments such as undergroundmines.Through Hovermap and other solutions, we deliver revolutionary efficiency, safety and operational insights to underground mines and other GPS-denied environments. Our growing team of experienced roboticists and engineers are dedicated to creating cutting-edge drone autonomy and data analytics for industrial applications. | $10.4M / Convertible Note / Jul 02, 2026 | |
Oricell Therapeutics
|
OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy. | $110M / Venture - Series Unknown / Apr 09, 2026 | |
Cauldron Ferm
|
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method. | $13.3M / Series A / Mar 24, 2026 | |
DeepWay
|
DeepWay is a maker and developer of intelligent electric commercial vehicles. | $310M / Jan 26, 2026 | |
|
Oricell Therapeutics
|
OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy. | $70M / Series C / Jan 12, 2026 | |
Lila Sciences
|
Lila Sciences is a platform that uses artificial intelligence to support research in life sciences, chemical sciences, and materials sciences. It develops AI-driven tools and autonomous labs to improve research efficiency and facilitate scientific discoveries. The platform is designed to enhance various aspects of the scientific method andcontribute to advancements in technology and innovation. | $115M / Series A / Oct 14, 2025 | |
Morse Micro
|
Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com | $58.1M / Series C / Sep 22, 2025 | |
|
Lila Sciences
|
Lila Sciences is a platform that uses artificial intelligence to support research in life sciences, chemical sciences, and materials sciences. It develops AI-driven tools and autonomous labs to improve research efficiency and facilitate scientific discoveries. The platform is designed to enhance various aspects of the scientific method andcontribute to advancements in technology and innovation. | $235M / Series A / Sep 14, 2025 | |
Airwallex
|
Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system. | $150M / Series F / May 21, 2025 | |
Inari
|
Inari is a biotech seed company that embraces diversity in every aspect of its business to drive innovation and help build a new food system. Our technology matches the complexity of nature using predictive design and multiplex gene editing to unlock the full potential of seed. We are always innovating, pushing the boundaries of what’s possible.Our SEEDesign platform is our point of distinction, using unsurpassed technology to enhance any crop for any geography to develop step-change products with a clear go-to-market approach. | $144M / Series G / Jan 07, 2025 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does NGS Super invest in?
NGS Super invests primarily in Software, Aerospace and Biotechnology startups, most often at Series A and Series C stage. Most of the 18 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NGS Super's check size?
NGS Super typically joins rounds of $13M–$235M at Series A, $20M–$29M at Series B and $46M–$70M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NGS Super participates in.
When did NGS Super last invest?
The most recent investment recorded for NGS Super closed in Jul 2026. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
